Tivan Limited (ASX:TVN) Awarded Grants for Sandover Fluorite Project
Tivan Limited (ASX:TVN) secures $150,000 in grants for its Sandover Fluorite Project, advancing exploration in central Australia.
Tag: Regulatory News & Compliance
Dateline Resources Limited (ASX:DTR) Announces OTCQB Uplisting and Colosseum Project Developments
Dateline Resources (ASX:DTR) announces OTCQB uplisting and updates on the Colosseum Gold-REE Project, boosting US investor access.
Toys’R’Us ANZ Limited (ASX:TOY) Appoints Voluntary Administrators
Toys’R’Us ANZ (ASX:TOY) appoints voluntary administrators amid insolvency risks, suspending ASX trading.
Mayne Pharma Group Limited (ASX:MYX) Updates on Scheme of Arrangement with Cosette
Mayne Pharma (ASX:MYX) updates investors on its Scheme of Arrangement with Cosette, addressing recent regulatory and contractual developments.
Engenco Limited (ASX:EGN) Receives Increased Takeover Offer
Elph Investments increases its takeover offer for Engenco Limited (ASX:EGN) from $0.305 to $0.31 per share.
Noxopharm Limited (ASX:NOX) Receives Approval for HERACLES Clinical Trial
Noxopharm Limited (ASX:NOX) receives ethics approval for its innovative HERACLES clinical trial, advancing new treatments for chronic inflammatory diseases.
St Barbara Limited (ASX:SBM) Confirms 15-Mile Processing Hub Development
St Barbara Limited (ASX:SBM) confirms a 3 Mtpa processing hub at 15-Mile, ensuring robust gold production and strong project economics.
Avecho Biotechnology Limited (ASX:AVE) Receives $1.66M R&D Tax Incentive
Avecho Biotechnology Limited (ASX:AVE) receives $1.66M under the R&D Tax Incentive to support its Phase III insomnia trial and commercialization efforts.
TerraCom Limited (ASX:TER) Reaches Agreement with ASIC on Whistleblower Proceedings
TerraCom Limited (ASX:TER) has settled ASIC whistleblower proceedings with a $7.5 million penalty, pending court approval.
Recce Pharmaceuticals (ASX:RCE) Secures China Patent for Anti-Infectives
Recce Pharmaceuticals (ASX:RCE) secures a China Patent for its RECCE® anti-infectives, enhancing its global intellectual property portfolio.